Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as Cannabidiol — Utah, 2017–2018
Authors:
- Roberta Z. HorthRHRoberta Z. Horth
- Barbara CrouchBCBarbara Crouch
- B. Zane HorowitzBHB. Zane Horowitz
- Amelia PrebishAPAmelia Prebish
- Matthew SlawsonMSMatthew Slawson
- Jennifer McNairJMJennifer McNair
- Chris ElsholzCEChris Elsholz
- Stephen GilleySGStephen Gilley
- Jenny RobertsonJRJenny Robertson
- Ilene RiskIRIlene Risk
- Mary HillMHMary Hill
- Linnea FletcherLFLinnea Fletcher
- 25 May 2018
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 67 (20) , 587-588
Abstract
CDC reports on poisonings from synthetic cannabinoid in Utah.Keywords
This publication has 5 references indexed in Scilit:
- Labeling Accuracy of Cannabidiol Extracts Sold OnlineJAMA, 2017
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet SyndromeNew England Journal of Medicine, 2017
- An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal StudiesCannabis & Cannabinoid Research, 2017
- Acute Poisonings from Synthetic Cannabinoids — 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010–2015MMWR. Morbidity and Mortality Weekly Report, 2016
- Severe Illness Associated with Reported Use of Synthetic Marijuana — Colorado, August–September 20132013